Dandelion Root to Treat Cancer - Quick Reference Sheet
evipedia.ai ← Back

Dandelion Root to Treat Cancer

Created on 07/10/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

In lab dishes and mice, a water-based dandelion root extract pushes many cancer cells to self-destruct while mostly sparing healthy cells. Human backing is almost absent: no completed trials, one stalled trial, a single case report. Everyday food safety is reassuring, but the gravest hazard is relying on it instead of proven cancer treatment. Biologically interesting, clinically unproven. (Full Review)

Protocol

Studied Preparation
Aqueous root extract
Concentrated water-based Taraxacum officinale root; differs from tea or capsules; no standardized clinical product
Traditional Amount
Dried root 2–8 g/day
Or tincture 1:5, 5–10 mL/day, or capsules; from digestive and diuretic use, not cancer trials
Dosing Schedule
Split 2–3× daily
Shortly before meals; daytime preferred to limit night-time urination
Time to effect
Anticancer Effect
No set timeframe
None should be assumed; not a proven treatment
Digestive Effect
Hours to days
Bitter stimulates digestion and bile flow
Diuretic Effect
Hours to days
Increased urination

Benefits

Contraindications
  • Asteraceae/ragweed allergy
  • Complete bile-duct obstruction, symptomatic gallstones, or acute cholecystitis
  • Active peptic ulcer disease
  • Warfarin without INR monitoring
  • Pregnancy or breastfeeding
  • Replacement for proven cancer treatment
    •
Key Interactions
  • Anticoagulants and antiplatelets (warfarin, clopidogrel, aspirin, heparin)
  • Blood-sugar-lowering drugs (metformin, sulfonylureas, insulin)
  • Diuretics (furosemide, hydrochlorothiazide) and lithium
  • Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin)
  • Drugs metabolized by liver enzymes (CYP1A2, CYP2C, CYP3A4)
  • Potassium-sparing agents and potassium supplements
  • NSAIDs, OTC diuretics, antacids and acid reducers
  • Anticoagulant, blood-sugar-lowering, diuretic, or high-oxalate supplements
  • Chemotherapy or radiotherapy
    •

Risk & Side Effects

  • High: Allergic reactions in Asteraceae-sensitive individuals
    •
  • Medium: Foregoing or delaying proven cancer treatment; herb–drug interactions affecting bleeding, blood sugar and fluid balance
    •
  • Low: Gastrointestinal upset and increased gastric and bile secretion; bile-duct and gallbladder complications; oxalate content and kidney-stone consideration; contamination of herbal products
    •
  • Speculative: Unknown safety of concentrated extracts at preclinical-equivalent exposures
    •

Monitoring

Marker Target Why
Serum potassium 4.0–4.5 mmol/L Dandelion is high in potassium and is a diuretic
Serum creatinine / eGFR eGFR >90 mL/min/1.73 m² Tracks kidney function under a diuretic load
ALT <25 U/L (men), <20 U/L (women) Screens for liver stress from herbal products
INR 2.0–3.0 if on warfarin; ~1.0 if not anticoagulated Detects altered clotting when combined with anticoagulants
Fasting glucose / HbA1c Fasting 75–90 mg/dL; HbA1c <5.4% Catches additive blood-sugar lowering with diabetes drugs
Complete blood count Within age- and sex-specific reference range Baseline and trend for blood-related cancers and marrow effects

Cadence: Baseline, review at 2–4 weeks after starting, then every 3–6 months; INR every 1–2 weeks when combined with warfarin, alongside the oncology team's scheduled restaging

Qualitative Assessment

  • Energy and fatigue levels
  • Digestive comfort, appetite and bowel regularity
  • Fluid balance (thirst, swelling, urination pattern)
  • Any skin rash, itching or mouth irritation suggesting allergy
  • Overall sense of wellbeing
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.